Allianz Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-42,400
| Closed | -$211K | – | 1650 |
|
2023
Q2 | $211K | Buy |
42,400
+21,600
| +104% | +$107K | ﹤0.01% | 1431 |
|
2023
Q1 | $103K | Buy |
+20,800
| New | +$103K | ﹤0.01% | 1578 |
|
2022
Q4 | – | Sell |
-20,900
| Closed | -$226K | – | 1485 |
|
2022
Q3 | $226K | Sell |
20,900
-24,385
| -54% | -$264K | ﹤0.01% | 1396 |
|
2022
Q2 | $516K | Hold |
45,285
| – | – | ﹤0.01% | 1658 |
|
2022
Q1 | $413K | Sell |
45,285
-9,300
| -17% | -$84.8K | ﹤0.01% | 1757 |
|
2021
Q4 | $819K | Buy |
54,585
+38,620
| +242% | +$579K | ﹤0.01% | 1662 |
|
2021
Q3 | $410K | Hold |
15,965
| – | – | ﹤0.01% | 1835 |
|
2021
Q2 | $416K | Buy |
+15,965
| New | +$416K | ﹤0.01% | 1731 |
|
2020
Q4 | – | Sell |
-17,895
| Closed | -$675K | – | 1821 |
|
2020
Q3 | $675K | Sell |
17,895
-1,643
| -8% | -$62K | ﹤0.01% | 1513 |
|
2020
Q2 | $837K | Buy |
+19,538
| New | +$837K | ﹤0.01% | 1456 |
|